{
  "id": 13238815,
  "title": "New Oral Drug Approved for Herpes Lesions",
  "url": "https://urgent.news/2026/10/09/new-oral-drug-approved-for-herpes-lesions",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T21:15:29.000Z",
  "source": {
    "name": "MedPage Today",
    "slug": "medpage-today",
    "url": "https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/123352"
  },
  "original_language": "en",
  "account": null,
  "summary": "(MedPage Today) -- The FDA approved pritelivir (Hovilpri) tablets to treat mucocutaneous lesions caused by herpes simplex virus (HSV) infections in immunocompromised patients who haven't responded to other treatments. Pritelivir, an oral helicase...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}